Development of a certified reference material for anti-β2-glycoprotein I IgG - commutability studies

被引:9
|
作者
Monogioudi, Evanthia [1 ]
Martos, Gustavo [1 ,2 ]
Sheldon, Joanna [3 ]
Meroni, Pier Luigi [4 ]
Trapmann, Stefanie [1 ]
Zegers, Ingrid [1 ]
机构
[1] European Commiss, Joint Res Ctr JRC, Geel, Belgium
[2] Int Bur Weights & Measures, Sevres, France
[3] St George Hosp, Prot Reference Unit, London, England
[4] Univ Milan, IRCCS Inst Auxol Italiano, Milan, Italy
关键词
autoimmune testing; certified reference materials; harmonization; proteinase; 3; standardization; STANDARDIZATION;
D O I
10.1515/cclm-2020-0995
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: In this paper, we describe the steps followed for the development of a certified reference material for immunoglobulin G antibodies against beta 2-glycoprotein I (also known as apolipoprotein H). These steps include processing of the material, commutability, the impact of dilution, the appropriate reconstitution conditions, homogeneity and stability during transport and storage. Methods: We analysed 69 clinical samples from patients suffering from antiphospholipid syndrome with several commercial enzyme-linked immunosorbent assays (ELISA) purchased from in vitro diagnostic manufacturers. Results: Analysis of the results indicated that the candidate reference material can be safely freeze-dried, and that the user should carefully follow the reconstitution instructions as small changes in e.g. temperature may have unwanted effects. The statistical analysis of the commutability studies indicated that the analytical response of the reference material upon dilution is similar to that of clinical samples, and that correlation between results may differ from assay to assay. Finally yet importantly, the presented and developed candidate reference material is commutable for most assays tested, homogeneous and stable. Conclusions: Immunoglobulin G antibodies against beta 2-glycoprotein I are associated with a higher risk of thrombosis and pregnancy complications. Their measurement is essential for the diagnosis and monitoring of antiphospholipid syndrome. These antibodies are detected by specific immunoassays, routinely used in clinical diagnostics, but various of these methods show enormous variability, in part due to the lack of a reference material.
引用
收藏
页码:325 / 332
页数:8
相关论文
共 50 条
  • [41] A chimeric antibody with the human γ1 constant region as a putative standard for assays to detect IgG β2-glycoprotein I-dependent anticardiolipin and anti-β2-glycoprotein I antibodies
    Ichikawa, K
    Tsutsumi, A
    Atsumi, T
    Matsuura, E
    Kobayashi, S
    Hughes, GRV
    Khamashta, MA
    Koike, T
    ARTHRITIS AND RHEUMATISM, 1999, 42 (11): : 2461 - 2470
  • [42] Heterogeneous behavior of anti-β2-glycoprotein I antibodies on various commercially available enzyme immunoassay plates coated with β2-glycoprotein I
    Tsutsumi, A
    Ichikawa, K
    Matsuura, E
    Sawada, KI
    Koike, T
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (02) : 391 - 396
  • [43] Anti-β2-glycoprotein I antibody-mediated inhibition of activated protein C requires binding of β2-glycoprotein I to phospholipids
    Izumi, T
    Pound, ML
    Su, ZW
    Iverson, GM
    Ortel, TL
    THROMBOSIS AND HAEMOSTASIS, 2002, 88 (04) : 620 - 626
  • [44] Effect of anti-β2-glycoprotein I and anti-prothrombin antibodies on platelet activation
    Ruggeri, L
    Galli, M
    Barbui, T
    THROMBOSIS AND HAEMOSTASIS, 1999, : 101 - 102
  • [45] Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I (vol 61, pg 35, 2015)
    Artenjak, A.
    Locatelli, I.
    Brelih, H.
    Simonic, D. M.
    Ulcova-Gallova, Z.
    Swadzba, J.
    Musial, J.
    Iwaniec, T.
    Stojanovich, L.
    Conti, F.
    Valesini, G.
    Avcin, T.
    Tervaert, J. W. Cohen
    Shoenfeld, Y.
    Blank, M.
    Ambrozic, A.
    Sodin-Semrl, S.
    Bozic, B.
    Cucnik, S.
    IMMUNOLOGIC RESEARCH, 2015, 61 (1-2) : 45 - 45
  • [46] Anti-β2-glycoprotein I antibody testing in the laboratory diagnosis of anti phospholipid syndrome
    Pengo, V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (06) : 1158 - 1159
  • [47] High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome
    Cucnik, S
    Kverder, T
    Krizaj, I
    Roaman, B
    Bozic, B
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (11) : 1478 - 1482
  • [48] Valine/Leucine247 polymorphism of β2-glycoprotein I in patients with antiphospholipid syndrome:: lack of association with anti-β2-glycoprotein I antibodies
    Swadzba, J
    Sanak, M
    Iwaniec, T
    Dziedzina, S
    Musial, J
    LUPUS, 2006, 15 (04) : 218 - 222
  • [49] Standardized antigen preparation to achieve comparability of anti-β2-glycoprotein I assays
    Mueller, Carolin
    Schlichtiger, Alice
    Balling, Gudrun
    Steigerwald, Udo
    Luppa, Peter B.
    Thaler, Markus
    THROMBOSIS RESEARCH, 2010, 126 (02) : E102 - E109
  • [50] Prevalence and isotype of antiphospholipid and anti-β2-glycoprotein I antibodies in alcoholic disease
    Barbare, JC
    Darnige, L
    Arvieux, J
    Laumonier, O
    Corbasson, C
    Capron, D
    Cadranel, JF
    Latrive, JP
    Piette, JC
    Capron, JP
    HEPATOLOGY, 1998, 28 (04) : 197A - 197A